In addition to methodological discrepancies, small APOE ɛ4 effect sizes and sample variability across cohorts, contradictory results may also be attributed to the complex midlife effects of the APOE ɛ4 gene as well as its interactions with other pathological markers of Alzheimer’s disease (i.e. amyloid and tau). This evidence concerns the gene APOE and Alzheimer disease.